Neumora Therapeutics (NMRA) Non-Current Assets (2022 - 2026)

Neumora Therapeutics' Non-Current Assets history runs 5 years deep, the most recent figure standing at $443000.0 for Q1 2026.

• In Q1 2026, Non-Current Assets fell 76.46% year-over-year to $443000.0; the TTM figure through Mar 2026 stood at $2.6 million (down 82.39% YoY), while the FY2025 annual figure was $510000.0, down 82.52% from the prior year.
• Non-Current Assets for Q1 2026 stood at $443000.0, down from $510000.0 in the prior quarter.
• The five-year high for Non-Current Assets was $38.3 million in Q4 2022, with the low at $443000.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $3.4 million (2024), against an average of $8.3 million.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets tumbled 53.2% in 2023, then slumped 85.12% in 2025.
• Neumora Therapeutics' Non-Current Assets stood at $38.3 million in 2022, then sank by 53.2% to $17.9 million in 2023, then tumbled by 83.72% to $2.9 million in 2024, then plunged by 82.52% to $510000.0 in 2025, then slipped by 13.14% to $443000.0 in 2026.
• Business Quant data shows NMRA's Non-Current Assets at $443000.0 in Q1 2026, $510000.0 in Q4 2025, and $751000.0 in Q3 2025.